eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Center for Drug Evaluation and Research Prescription Drug Labeling Improvement and Enhancement Initiative; Request for Comments and Information

Center for Drug Evaluation and Research Prescription Drug Labeling Improvement and Enhancement Initiative; Request for Comments and Information

Document ID: FDA-2013-N-0059-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2013-02528
View Document:  View as format pdf

Details Information

Document Subtype: General Notice
Received Date: February 06 2013, at 12:00 AM Eastern Standard Time
Start-End Page: 8446 - 8448
Page Count: 3
Comment Start Date: February 6 2013, at 12:00 AM Eastern Standard Time
Comment Due Date: March 8 2013, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 15
Janssen Research & Development - Comment
Posted: 03/20/2013     ID: FDA-2013-N-0059-0010

Mar 08,2013 11:59 PM ET
Lupus Foundation of Mid and Northern New York - Comment
Posted: 03/20/2013     ID: FDA-2013-N-0059-0008

Mar 08,2013 11:59 PM ET
Baxter Healthcare Corporation - Comment
Posted: 03/20/2013     ID: FDA-2013-N-0059-0007

Mar 08,2013 11:59 PM ET
Teva Pharmaceuticals - Comment
Posted: 03/20/2013     ID: FDA-2013-N-0059-0009

Mar 08,2013 11:59 PM ET
Association for Molecular Pathology (AMP) - Comment
Posted: 03/20/2013     ID: FDA-2013-N-0059-0003

Mar 08,2013 11:59 PM ET

Related Documents

Total: 0
No documents available.